Comparison Clarus Therapeutics (BLUW) with Competitors
Clarus Therapeutics (BLUW) industry is Shell Companies.
Debt-to-Equity
BLUW0.20%
Industry-12.05%
Upside+12.25%
Free Cash Flow Yield
BLUW-0.14%
Industry-0.32%
Upside+0.18%
P/B
BLUW1.32
Industry1.76
Upside-25.31%